ATARA BIOTHERAPEUTICS, INC. Current Income Tax Expense (Benefit)
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Current Income Tax Expense (Benefit) of $31.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-03-16
- ATARA BIOTHERAPEUTICS, INC. current income tax expense (benefit) for fiscal 2025 was $31.00K.
- ATARA BIOTHERAPEUTICS, INC. current income tax expense (benefit) for fiscal 2024 was -$12.00K, a 180.00% decline from fiscal 2023.
- ATARA BIOTHERAPEUTICS, INC. current income tax expense (benefit) for fiscal 2023 was $15.00K, a 25.00% increase from fiscal 2022.
- ATARA BIOTHERAPEUTICS, INC. current income tax expense (benefit) for fiscal 2022 was $12.00K, a 73.91% decline from fiscal 2021.
| Period end | Current Income Tax Expense (Benefit) 4 month | Current Income Tax Expense (Benefit) 12 month |
|---|---|---|
| 2025-12-31 | $31.00K 10-K · filed 2026-03-16 | |
| 2024-12-31 | -$12.00K 10-K · filed 2026-03-16 | |
| 2023-12-31 | $15.00K 10-K · filed 2025-03-07 | |
| 2022-12-31 | $12.00K 10-K · filed 2024-03-28 | |
| 2021-12-31 | $46.00K 10-K · filed 2023-02-08 | |
| 2020-12-31 | $15.00K 10-K · filed 2023-02-08 | |
| 2019-12-31 | $12.00K 10-K · filed 2022-02-28 | |
| 2018-12-31 | -$44.00K 10-K · filed 2021-03-01 | |
| 2017-12-31 | -$14.00K 10-K · filed 2020-02-27 | |
| 2016-12-31 | $10.00K 10-K · filed 2019-02-26 | |
| 2015-12-31 | -$9.00K 10-K · filed 2018-02-27 | |
| 2014-12-31 | -$25.00K 10-K · filed 2017-03-09 | |
| 2013-12-31 | $170.00K 10-K · filed 2016-03-04 | |
| 2012-12-31 | $17.00K 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |